DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ghielmini M, Schmitz SF, Cogliatti SB, Pichert G, Hummerjohann J, Waltzer U, Fey MF, Betticher DC, Martinelli G, Peccatori F, Hess U, Zucca E, Stupp R, Kovacsovics T, Helg C, Lohri A, Bargetzi M, Vorobiof D, Cerny T.
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule.
Blood 2004; 103: 4416-4423
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.